World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
41621
World Ranking
7327
National Ranking
244

Maurilio Ponzoni publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Maurilio Ponzoni sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 528 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Maurilio Ponzoni D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Maurilio Ponzoni sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Maurilio Ponzoni is affiliated with Vita-Salute San Raffaele University in Italy. Their research primarily focuses on medical fields including pathology and forensic medicine, oncology, immunology, genetics, and neurology.

The scientist has published extensively in the domain of medicine, with 270 publications addressing various subfields and specialized topics. The notable subfields include pathology and forensic medicine with 75 publications, oncology with 51, immunology with 47, genetics with 46, and neurology covering 25 publications.

The main topics of their research cover several aspects of hematological malignancies and immune system interactions. Specific areas addressed are lymphoma diagnosis and treatment (140 publications), chronic lymphocytic leukemia research (68), primary central nervous system (CNS) lymphoma diagnosis and treatment (50), CAR-T cell therapy research (40), viral-associated cancers and disorders (38), immune cell function and interaction (24), and glioma diagnosis and treatment (18).

They have contributed to multiple frequent publication venues including:

  • Hematological Oncology (22 publications)
  • Blood (11 publications)
  • UNC Libraries (8 publications)
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (8 publications)
  • Blood Advances (7 publications)

Their published papers include:

  • Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2020), Annals of Oncology
  • Primary central nervous system lymphoma (2023), Nature Reviews Disease Primers
  • Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial (2022), Leukemia
  • Genetic and phenotypic attributes of splenic marginal zone lymphoma (2021), Blood
  • MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study (2021), British Journal of Haematology

Frequent co-authors who have collaborated with Maurilio Ponzoni include:

  • Andrés J.M. Ferreri (65 collaborations)
  • Alexandar Tzankov (27 collaborations)
  • Govind Bhagat (26 collaborations)
  • Carlo Visco (25 collaborations)
  • Emanuele Zucca (23 collaborations)

Best Publications

  • HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia

    Chiara Bonini;Giuliana Ferrari;Simona Verzeletti;Paolo Servida

  • Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

    Margherita Norelli;Barbara Camisa;Giulia Barbiera;Laura Falcone

  • Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma

    Mara Compagno;Wei Keat Lim;Adina Grunn;Subhadra V. Nandula

  • Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    Andrés J M Ferreri;Jean Yves Blay;Michele Reni;Felice Pasini

  • Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

    Eugenio Montini;Daniela Cesana;Manfred Schmidt;Francesca Sanvito

  • Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients.

    S A Pileri;S Ascani;M C Cox;C Campidelli

  • High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

    Andrés J. M. Ferreri;Michele Reni;Marco Foppoli;Maurizio Martelli

  • Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

    Andrés J. M. Ferreri;Elías Campo;John F. Seymour;Rein Willemze

  • Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas

    Andrés J. M. Ferreri;Massimo Guidoboni;Maurilio Ponzoni;Carlo De Conciliis

  • The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.

    Eugenio Montini;Daniela Cesana;Manfred Schmidt;Francesca Sanvito

  • Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

    Emanuele Zucca;Annarita Conconi;Ennio Pedrinis;Sergio Cortelazzo

  • Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

    Andrés J M Ferreri;Kate Cwynarski;Elisa Pulczynski;Maurilio Ponzoni

  • Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

    Mary Anna Venneri;Michele De Palma;Maurilio Ponzoni;Ferdinando Pucci

  • Genetics of Follicular Lymphoma Transformation

    Laura Pasqualucci;Hossein Khiabanian;Marco Fangazio;Mansi Vasishtha

  • MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

    Shimin Hu;Zijun Y. Xu-Monette;Alexander Tzankov;Tina Green

  • Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer

    Elena Provasi;Pietro Genovese;Angelo Lombardo;Zulma Magnani

  • Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting

    Maurilio Ponzoni;Andrés J.M. Ferreri;Elías Campo;Fabio Facchetti

  • Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

    Annarita Conconi;Giovanni Martinelli;Catherine Thiéblemont;Andrés J M Ferreri

  • Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

    Ramona Crescenzo;Ramona Crescenzo;Francesco Abate;Francesco Abate;Francesco Abate;Elena Lasorsa;Fabrizio Tabbo;Fabrizio Tabbo

  • Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

    Fabio Ciceri;Chiara Bonini;Maria Teresa Lupo Stanghellini;Attilio Bondanza

Frequent Co-Authors

Andrés J.M. Ferreri
Andrés J.M. Ferreri Vita-Salute San Raffaele University
Miguel A. Piris
Miguel A. Piris Instituto de Salud Carlos III
Claudio Doglioni
Claudio Doglioni Vita-Salute San Raffaele University
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Francesco Bertoni
Francesco Bertoni Institute of Oncology Research
Govind Bhagat
Govind Bhagat Columbia University
Eric D. Hsi
Eric D. Hsi Cleveland Clinic
Youli Zu
Youli Zu Houston Methodist
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Santiago Montes-Moreno
Santiago Montes-Moreno Instituto de Investigación Marqués de Valdecilla

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine in the USA opens doors to various online degree options and specialized career paths. For those aiming for advanced practice, earning an easiest dnp program online can help experienced nurses achieve leadership roles while balancing work and study.

If you're looking to quickly enter the healthcare workforce, a lpn program offers an accelerated pathway to become a Licensed Practical Nurse. These programs are ideal for those who want to make an impact in patient care without spending years in school.

Mental health is a rapidly growing field. Qualified nurses may advance their careers through online pmhnp programs, specializing in psychiatric and mental health.

For those interested in the business and management side of healthcare, pursuing a bachelors in health administration can lead to roles in hospital management, policy, and beyond. These online options provide flexibility for diverse student needs and career goals.

Best Scientists Citing Maurilio Ponzoni

Trending Scientists